[Skip to Content]
[Skip to Content Landing]
Citations 0
Editor's Correspondence
November 26, 2001

Start Low, Go Slow, Is Not Always Best

Arch Intern Med. 2001;161(21):2623. doi:

In the article by Cohen1 about adverse drug effects and compliance, the author appears to advocate a "start low, go slow" approach. While this approach has merit, and may minimize adverse effects, it has an important psychological flaw, which may diminish compliance. It is hard enough for patients to begin long-term treatment for a chronic disease. If they start a medication regimen, then undergo dose titrations or medication changes, they may perceive such adjustments as failures, become frustrated, and discontinue use. I agree with the author when he advocates flexible, individualized prescribing.

First Page Preview View Large
First page PDF preview
First page PDF preview